Gamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a 111In-labeled cyclic peptide

Nuclear Medicine and Biology

Volumn 36, Issue 3, 2009, Pages 259-266

  Yang, Zhi ^a   Kontoyiannis, Dimitrios P ^a   Wen, Xiaoxia ^a   Xiong, Chiyi ^a   Zhang, Rui ^a   Albert, Nathaniel D ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aspergillosis; Cyclic peptide; Fungal infection; Gamma scintigraphy; Indium 111

Indexed keywords

CYCLOPEPTIDE; PENTETIC ACID; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; AUTORADIOGRAPHY; CONTROL GROUP; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; GAMMA SCINTIGRAPHY; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; PHOTOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ASPERGILLUS FUMIGATUS; AUTORADIOGRAPHY; FEMALE; HYPHAE; INDIUM RADIOISOTOPES; INVASIVE PULMONARY ASPERGILLOSIS; KINETICS; MICE; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN STABILITY; REPRODUCIBILITY OF RESULTS; SPORES, FUNGAL; STAINING AND LABELING; TISSUE DISTRIBUTION;

EID: 62549119549     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.12.004     Document Type: Article

References (35)

1. Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002;16:875-94, vi.
2. Pannuti C., Gingrich R., Pfaller M.A., Kao C., and Wenzel R.P. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer 69 (1992) 2653-2662
3. Petraitis V., Petraitiene R., Solomon J., et al. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis. Antimicrob Agents Chemother 50 (2006) 1510-1517
4. Wald A., Leisenring W., van Burik J.A., and Bowden R.A. Epidemiology of aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175 (1997) 1459-1466
5. Kontoyiannis D.P., and Bodey G.P. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 21 (2002) 161-172
6. Latge J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12 (1999) 310-350
7. Soubani A.O., and Qureshi M.A. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Haematologia (Budap) 32 (2002) 427-437
8. Trullas J.C., Cervera C., Benito N., et al. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc 37 (2005) 4091-4093
9. Ellis M. Invasive fungal infections; evolving challenges for diagnosis and therapeutics. Mol Immunol 38 (2001) 947-957
10. Busca A., Locatelli F., Barbui A., et al. Usefulness of sequential aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. Transplant Proc 38 (2006) 1610-1613
11. Khot P.D., Ko D.L., Hackman R.C., and Fredricks D.N. Development and optimization of quantitative pcr for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis 8 (2008) 73
12. Tsan M.F. Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med 26 (1985) 88-92
13. Palestro C.J., Love C., Tronco G.G., Tomas M.B., and Rini J.N. Combined labeled leukocyte and technetium-99 m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics 26 (2006) 859-870
14. 18F-FDG-labeled white blood cells versus 18f-fdg. J Nucl Med 46 (2005) 1522-1530
15. 99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections. Chest 126 (2004) 1954-1961
16. van Eerd J.E., Rennen H.J., Oyen W.J., et al. Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist. J Nucl Med 45 (2004) 1747-1753
17. Becker W., Bair J., Behr T., et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med 35 (1994) 1436-1443
18. Harwood S.J., Valdivia S., Hung G.L., and Quenzer R.W. Use of sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis 28 (1999) 1200-1205
19. Chen D.L., and Schuster D.P. Imaging pulmonary inflammation with positron emission tomography: a biomarker for drug development. Mol Pharm 3 (2006) 488-495
20. 18F-FDG pet in detecting metastatic infectious disease. J Nucl Med 46 (2005) 2014-2019
21. 18 F-Fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 23 (2005) 7857-7863
22. 18F]-fluoro-d-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease. Mol Imaging Biol 4 (2002) 201-207
23. Lionakis M.S., Lahdenranta J., Sun J., et al. Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infect Immun 73 (2005) 7747-7758
24. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 19 (2001) 316-317
25. Wang W., McMurray J.S., Wu Q., Campbell M.L., and Li C. Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)-conjugated cyclic RGD peptide analogues. Cancer Biother Radiopharm 20 (2005) 547-556
26. Lewis R.E., Prince R.A., Chi J., and Kontoyiannis D.P. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin b therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother 46 (2002) 3208-3214
27. Dadachova E., Nakouzi A., Bryan R.A., and Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 100 (2003) 10942-10947
28. Wong J.Y., Thomas G.E., Yamauchi D., et al. Clinical evaluation of indium-111-labeled chimeric anti-cea monoclonal antibody. J Nucl Med 38 (1997) 1951-1959
29. Siaens R., Eijsink V.G., Dierckx R., and Slegers G. (123)I-Labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice. J Nucl Med 45 (2004) 1209-1216
30. Koivunen E., Arap W., Valtanen H., et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17 (1999) 768-774
31. Nilsson F., Tarli L., Viti F., and Neri D. The use of phage display for the development of tumour targeting agents. Adv Drug Deliv Rev 43 (2000) 165-196
32. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315-1317
33. Koivunen E., Wang B., and Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (NY) 13 (1995) 265-270
34. Su Z.F., Liu G., Gupta S., et al. In vitro and in vivo evaluation of a technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(v)beta(3) integrin for tumor imaging. Bioconjug Chem 13 (2002) 561-570
35. Zitzmann S., Mier W., Schad A., et al. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 11 (2005) 139-146